Insider Transactions in Q3 2022 at Rani Therapeutics Holdings, Inc. (RANI)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 09
2022
|
Svai S Sanford Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,362
-13.2%
|
$165,258
$9.89 P/Share
|
Sep 09
2022
|
Mir Hashim Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,334
-12.8%
|
$183,006
$9.89 P/Share
|
Aug 23
2022
|
Mir A Imran |
BUY
Conversion of derivative security
|
Indirect |
7,694
+9.4%
|
-
|
Aug 23
2022
|
Mir A Imran |
SELL
Conversion of derivative security
|
Indirect |
7,694
-0.03%
|
-
|
Aug 23
2022
|
Andrew Farquharson |
BUY
Conversion of derivative security
|
Indirect |
7,694
+9.56%
|
-
|
Aug 23
2022
|
Andrew Farquharson |
SELL
Conversion of derivative security
|
Indirect |
7,694
-3.0%
|
-
|
Aug 17
2022
|
Andrew Farquharson |
SELL
Open market or private sale
|
Indirect |
80,252
-30.63%
|
$882,772
$11.07 P/Share
|
Aug 17
2022
|
Mir A Imran |
SELL
Open market or private sale
|
Indirect |
80,252
-30.3%
|
$882,772
$11.07 P/Share
|